Ryan Weisfenning
Vice President and Head of Medtronic Investor Relations
Replay available
Medtronic plc (NYSE: MDT) Q4 2025 earnings conference call, held 2025-05-21. Replay captured from the company's public earnings webcast.

Vice President and Head of Medtronic Investor Relations
Chairman and Chief Executive Officer
EVP and President of Diabetes
Chief Financial Officer
Participant
Analyst at UBS
Analyst at Barclays
Analyst at J.P. Morgan
Analyst at Wells Fargo
Analyst at Jefferies
EVP and President of Neuroscience Portfolio
EVP and President of the Cardiovascular Portfolio
Analyst at ABC
Good morning. I'm Ryan Weisfenning, Vice President and Head of Medtronic Investor Relations. And I appreciate that you're joining us for our fiscal 25 fourth quarter video earnings webcast. Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast. Joining me are Jeff Martha, Chairman and Chief Executive Officer, and Thierry Piatone, Chief Financial Officer. Jeff and Thierry will provide comments on the results of our fourth quarter, which ended on April 25th, 2025, and our outlook for fiscal year 26. After our prepared remarks, the executive VPs from each of our four segments will join us and we'll take questions from the sell side analysts that cover the company. Today's program should last between 60 and 90 minutes. Earlier this morning, we issued a press release containing our financial statements, divisional and geographic revenue summaries, and non-GAAP reconciliations. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com. During today's program, many of the statements we make may be considered forward-looking statements, and actual results may differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause our actual results to differ is contained with our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. Unless we say otherwise, all comparisons are on a year-over-year basis, and revenue comparisons are made on an organic basis, which excludes the impact of foreign currency and fourth quarter revenue in the current and prior y...